Apollo Newsletter_A4_09032016
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Other key Projects & Activities<br />
<strong>Apollo</strong> Research Bulletin<br />
USV – Investigator Initiated Study for<br />
Type II Diabetes Drug<br />
<strong>Apollo</strong> has recently signed an agreement with USV<br />
for a phase IV Investigator Initiated Study in Type 2<br />
diabetes in Indian population. The study duration<br />
is 1 year and is being conducted by 5 investigator<br />
across 4 <strong>Apollo</strong> centers. It is one of the larger studies<br />
initiated by investigators.<br />
Genpraxis – Remote Genetic Counseling Platform<br />
Genpraxis is a provider of next generation<br />
sequencing clinical diagnostics for inherited disease<br />
and precision medicine. It is entering into remote<br />
genetic counseling sector where single platform will<br />
provide one stop shop for physician and patients.<br />
ARI has assisted HNG in closing a term sheet to<br />
realize this venture. The Genepraxis is a spin off<br />
from Yale University & shall enable opening a larger<br />
collaboration.<br />
Lipotest Meal - Diagnostic meal for performing Fat Tolerance<br />
Test<br />
The test is developed by D-Genomeres, Greece. The Lipotest-meal is a diagnostic<br />
meal used for diagnosing the abnormal postprandial lipaemia (Fat Tolerance Test). It<br />
is the meal that someone consumes in order to perform the Fat Tolerance Test. The<br />
lipo-test meal used in OFTT is a diagnostic tool which is given as a mousse in fasting<br />
condition to patients.<br />
ARI has completed the study and the outcome are<br />
in line with the current knowledge.<br />
In the absence of a standardized fat tolerance test<br />
in India, Lipotest meal provides an opportunity<br />
to test the postprandial lipemia as a risk factor<br />
for cardiovascular disease.<br />
11
Change language